iddl
east
respiratori
syndrom
coronaviru
mersfrom
patient
die
pneumonia
saudi
arabia
merscov
infect
result
respiratori
tract
ill
report
world
health
organ
case
fatal
known
case
directli
indirectli
link
countri
arabian
peninsula
dromedari
camel
across
beyond
region
show
high
rate
antibodi
merscov
viral
rna
detect
camel
differ
countri
instanc
camel
human
care
camel
found
infect
virus
highli
similar
distinct
within
nt
camelderiv
viru
sequenc
includ
sever
phylogenet
inform
nucleotid
chang
investig
possibl
camelhuman
viru
transmiss
analyz
infect
merscov
man
contact
infect
camel
novemb
ministri
health
saudi
infect
male
patient
king
abdulaziz
univers
hospit
jeddah
patient
care
ill
camel
herd
anim
start
earli
octob
patient
note
respiratori
sign
ill
nasal
discharg
sever
anim
continu
care
sick
anim
octob
day
onset
per
day
day
per
week
appli
herbal
remedi
anim
snout
nostril
clean
stabl
milk
anim
routin
consum
raw
unpasteur
camel
milk
herd
presenc
merscov
rna
patient
contranscript
pcr
rtpcr
target
upe
orfa
gene
fragment
respiratori
swab
specimen
yield
detect
signal
rtpcr
cycl
indic
approxim
viral
load
rna
copi
per
sampl
nearli
complet
viral
genom
obtain
genbank
access
con
phylogeni
shown
onlin
technic
appendix
figur
identifi
potenti
sourc
infect
novemb
ministri
health
investig
close
household
contact
anim
attend
farm
own
patient
nasopharyng
swab
sampl
taken
test
jeddah
region
laboratori
use
rtpcr
deep
nasal
swab
specimen
taken
day
camel
farm
test
sampl
rtpcr
use
upe
assay
detect
merscov
rna
human
patient
camel
camel
g
test
posit
cycl
threshold
c
novemb
nasal
swab
sampl
obtain
anim
upe
rtpcr
result
posit
camel
g
c
second
camel
camel
b
c
sampl
novemb
small
remain
amount
rna
extract
camel
g
novemb
sent
sanger
institut
cambridg
uk
sampl
upe
assay
camel
g
camel
virolog
bonn
germani
sampl
use
realtim
rtpcr
target
upe
diagnost
target
region
determin
rtpcr
fragment
partial
overlap
nt
total
phylogenet
analys
support
conclus
transmiss
occur
camel
patient
direct
impli
eg
camel
human
vs
human
camel
onlin
technic
appendix
figur
humanand
camelderiv
sequenc
share
signatur
singl
nucleotid
polymorph
occur
known
merscov
sequenc
figur
singl
nucleotid
exchang
occur
nt
posit
exchang
might
come
arisen
viru
transmiss
describ
howev
low
rna
concentr
sampl
pcrbase
mutat
could
done
serum
sampl
taken
camel
g
initi
investig
novemb
test
recombin
show
reactiv
merscov
titer
investig
sign
recent
merscov
infect
group
camel
obtain
blood
sampl
short
interv
anim
novemb
sampl
test
elisa
recombin
merscov
spike
antigen
domain
fuse
human
fc
fragment
use
formul
describ
serum
sampl
anim
show
reactiv
merscov
antigen
serum
sampl
control
anim
show
reactiv
onlin
technic
appendix
figur
panel
elisa
signal
constant
time
anim
small
yet
visibl
chang
signal
observ
period
note
camel
b
g
clarifi
serum
sampl
obtain
novemb
decemb
anim
retest
ifa
summar
tabl
camel
b
g
show
increas
test
reli
endpoint
titrat
titer
increas
sequenti
sampl
camel
b
g
compar
sequenti
sampl
camel
e
use
ifa
titer
camel
b
g
onlin
technic
appendix
figur
panel
b
bovin
cov
occur
camel
test
antibodi
bovin
cov
camel
b
g
exclud
potenti
crossreact
use
ifa
found
bovin
cov
antibodi
camel
g
camel
b
show
rise
bovin
cov
antibodi
titer
tabl
obtain
differenti
perform
neutral
assay
merscov
bovin
cov
titer
serum
sampl
novemb
decemb
respect
camel
b
camel
g
none
anim
show
serum
neutral
bovin
cov
similar
merscov
carri
human
camel
support
hypothesi
human
merscov
infect
may
acquir
directli
camel
addit
anim
show
sign
recent
infect
juvenil
provid
support
merscov
given
synchron
parturit
pattern
dromedari
camel
birth
winter
month
increas
epizoot
activ
might
year
data
provid
particular
insight
time
infect
transmiss
antibodi
titer
rose
viral
rna
concentr
alreadi
declin
camel
patient
hospit
acut
symptom
assum
time
appear
antibodi
day
least
camel
would
activ
infect
middl
late
octob
anim
show
sign
respiratori
ill
patient
acquir
infect
nevertheless
rule
infecti
caus
anim
upper
respiratori
sign
also
retrospect
natur
investig
rule
possibl
third
sourc
merscov
infect
camel
human
camel
g
sampl
taken
novemb
also
avail
yield
immunofluoresc
titer
